Our findings contribute to a better understanding of the bone resorption process and suggest that inhibiting IRAK-4 could be a therapeutic strategy to combat oral infections caused by E. faecalis in apical periodontitis or other oral diseases characterized by bone destruction. This evidence concerns the gene IRAK4 and mouth disorder.